{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:30:27Z","timestamp":1793316627590,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>We aimed to compare diabetic retinopathy outcomes in people with type 1 diabetes following introduction of continuous subcutaneous insulin infusion (CSII) therapy with outcomes in people receiving continuing therapy with multiple daily insulin injections (MDI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective cohort study using the Scottish Care Information \u2013 Diabetes database for retinal screening outcomes and HbA<jats:sub>1c<\/jats:sub> changes in 204 adults commenced on CSII therapy between 2013 and 2016, and 211 adults eligible for CSII during the same period but who continued on MDI therapy. Diabetic retinopathy progression (time to minimum one-grade worsening in diabetic retinopathy from baseline grading) was plotted for CSII and MDI cohorts using Kaplan\u2013Meier curves, and outcomes were compared using multivariate Cox regression analysis adjusting for age, sex, baseline HbA<jats:sub>1c<\/jats:sub>, blood pressure, cholesterol, smoking status and socioeconomic quintile. Impact of baseline HbA<jats:sub>1c<\/jats:sub> and change in HbA<jats:sub>1c<\/jats:sub> on diabetic retinopathy progression was assessed within CSII and MDI cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CSII participants were significantly younger, were from less socially deprived areas, and had lower HbA<jats:sub>1c<\/jats:sub> and higher diastolic BP at baseline. There was a larger reduction in HbA<jats:sub>1c<\/jats:sub> at 1\u00a0year in those on CSII vs MDI (\u22126\u00a0mmol\/mol [\u22120.6%] vs \u22122\u00a0mmol\/mol [\u22120.2%], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Diabetic retinopathy progression occurred in a smaller proportion of adults following commencement of CSII vs continued MDI therapy over mean 2.3\u00a0year follow-up (26.5% vs 18.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0097). High baseline HbA<jats:sub>1c<\/jats:sub> (75\u00a0mmol\/mol [9%]) was associated with diabetic retinopathy progression in the MDI group (<jats:italic>p<\/jats:italic>\u2009=\u20090.0049) but not the CSII group (<jats:italic>p<\/jats:italic>\u2009=\u20090.93). Change in HbA<jats:sub>1c<\/jats:sub> at follow-up, irrespective of baseline glycaemic status, did not significantly affect diabetic retinopathy progression in either group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>CSII was associated with reduced diabetic retinopathy progression compared with continued MDI therapy, and may be protective against diabetic retinopathy progression for those with high baseline HbA<jats:sub>1c<\/jats:sub>. Progression of diabetic retinopathy over 3\u00a0years was not associated with a change in HbA<jats:sub>1c<\/jats:sub>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-021-05456-w","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T19:02:17Z","timestamp":1620500537000},"page":"1725-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin"],"prefix":"10.1007","volume":"64","author":[{"given":"Laura J.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser W.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Colhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W. J.","family":"Strachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Madill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljean","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareen","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"3","key":"5456_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"issue":"9","key":"5456_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR et al (2016) Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010. Diabetes Care 39(9):1643\u20131649. https:\/\/doi.org\/10.2337\/dc15-2171","journal-title":"Diabetes Care"},{"key":"5456_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM (2014) The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care 37:9\u201316","journal-title":"Diabetes Care"},{"issue":"1","key":"5456_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","volume":"44","author":"S Feldman-Billard","year":"2018","unstructured":"Feldman-Billard S, Larger E, Massin P (2018) Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab 44(1):4\u201314. https:\/\/doi.org\/10.1016\/j.diabet.2017.10.014","journal-title":"Diabetes Metab"},{"key":"5456_CR5","unstructured":"Diabetic Retinopathy Guidelines Expert Working Party (2012) The Royal College of Ophthalmologists Diabetic Retinopathy Guidelines December 2012. Available from https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2014\/12\/2013-SCI-301-FINAL-DR-GUIDELINES-DEC-2012-updated-July-2013.pdf. Accessed 10 Jun 2020"},{"key":"5456_CR6","doi-asserted-by":"publisher","unstructured":"Misso ML, Egberts KJ, Page M, O\u2019Connor D, Shaw J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev Art. no.: CD005103. https:\/\/doi.org\/10.1002\/14651858.CD005103.pub2","DOI":"10.1002\/14651858.CD005103.pub2"},{"issue":"3","key":"5456_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/diacare.7.3.236","volume":"7","author":"E van Ballegooie","year":"1984","unstructured":"van Ballegooie E, Hooymans JM, Timmerman Z et al (1984) Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 7(3):236\u2013242. https:\/\/doi.org\/10.2337\/diacare.7.3.236","journal-title":"Diabetes Care"},{"issue":"8","key":"5456_CR8","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archopht.1984.01040030934017","volume":"102","author":"TM Kelly","year":"1984","unstructured":"Kelly TM, Sanborn GE, Haug PJ, Edwards CQ (1984) Effect of insulin infusion pump use on diabetic retinopathy. Arch Ophthalmol 102(8):1156\u20131159. https:\/\/doi.org\/10.1001\/archopht.1984.01040030934017","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"5456_CR9","doi-asserted-by":"publisher","first-page":"e0153033","DOI":"10.1371\/journal.pone.0153033","volume":"11","author":"B Zabeen","year":"2016","unstructured":"Zabeen B, Craig ME, Virk SA et al (2016) Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality. PLoS One 11(4):e0153033. https:\/\/doi.org\/10.1371\/journal.pone.0153033","journal-title":"PLoS One"},{"key":"5456_CR10","unstructured":"Scottish Diabetic Retinopathy Screening Collaborative (2007) Scottish Diabetic Retinopathy Grading Scheme 2007 v1.1. Available from https:\/\/www.ndrs.scot.nhs.uk\/wp-content\/uploads\/2013\/04\/Grading-Scheme-2007-v1.1.pdf. Accessed 10 Jun 2020"},{"key":"5456_CR11","unstructured":"Scottish Government (2016) Scottish Index of Multiple Deprivation. Available from https:\/\/www2.gov.scot\/Topics\/Statistics\/SIMD\/. Accessed 1 Dec 2020"},{"issue":"6","key":"5456_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/aos.13066","volume":"94","author":"ON Klefter","year":"2016","unstructured":"Klefter ON, Hommel E, Munch IC, Norgaard K, Madsbad S, Larsen M (2016) Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study. Acta Ophthalmol 94(6):540\u2013547. https:\/\/doi.org\/10.1111\/aos.13066","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"5456_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"RJ Wright","year":"2008","unstructured":"Wright RJ, Frier BM (2008) Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 24(5):353\u2013363. https:\/\/doi.org\/10.1002\/dmrr.865","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"5456_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/dme.13094","volume":"33","author":"C Quiros","year":"2016","unstructured":"Quiros C, Gimenez M, Rios P et al (2016) Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Diabet Med 33(10):1422\u20131426. https:\/\/doi.org\/10.1111\/dme.13094","journal-title":"Diabet Med"},{"issue":"8","key":"5456_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group (1995) The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial. Diabetes 44(8):968\u2013983. https:\/\/doi.org\/10.2337\/diab.44.8.968","journal-title":"Diabetes"},{"issue":"5","key":"5456_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/1932296817700161","volume":"11","author":"L Marchand","year":"2017","unstructured":"Marchand L, Kawasaki-Ogita Y, Place J et al (2017) Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes. J Diabetes Sci Technol 11(5):924\u2013929. https:\/\/doi.org\/10.1177\/1932296817700161","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"5456_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD et al (2019) Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care 42(3):400\u2013405. https:\/\/doi.org\/10.2337\/dc18-1444","journal-title":"Diabetes Care"},{"key":"5456_CR18","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2337\/dc09-0109","volume":"32","author":"ES Kilpatrick","year":"2009","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL (2009) Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes. Diabetes Care 32:1901\u20131903. https:\/\/doi.org\/10.2337\/dc09-0109","journal-title":"Diabetes Care"},{"issue":"8","key":"5456_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 42(8):1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"issue":"11","key":"5456_CR20","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu J, Ma X, Zhou J et al (2018) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care 41(11):2370\u20132376. https:\/\/doi.org\/10.2337\/dc18-1131","journal-title":"Diabetes Care"},{"issue":"4","key":"5456_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1463-1326.2009.01160.x","volume":"12","author":"L Nalysnyk","year":"2010","unstructured":"Nalysnyk L, Hernandez-Medina M, Krishnarajah G (2010) Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 12(4):288\u2013298. https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01160.x","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"5456_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jdiacomp.2014.11.013","volume":"29","author":"CR Hsu","year":"2015","unstructured":"Hsu CR, Chen YT, Sheu WH (2015) Glycemic variability and diabetes retinopathy: a missing link. J Diabetes Complicat 29(2):302\u2013306. https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.11.013","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"5456_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","volume":"50","author":"G Sartore","year":"2013","unstructured":"Sartore G, Chilelli NC, Burlina S, Lapolla A (2013) Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol 50(3):437\u2013442. https:\/\/doi.org\/10.1007\/s00592-013-0459-9","journal-title":"Acta Diabetol"},{"issue":"3","key":"5456_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/TP.0b013e31820437f3","volume":"91","author":"DM Thompson","year":"2011","unstructured":"Thompson DM, Meloche M, Ao Z et al (2011) Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 91(3):373\u2013378. https:\/\/doi.org\/10.1097\/TP.0b013e31820437f3","journal-title":"Transplantation"},{"issue":"7","key":"5456_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s2213-8587(18)30107-4","volume":"6","author":"S Forbes","year":"2018","unstructured":"Forbes S, Senior PA, Shapiro AMJ (2018) Islet transplantation in type 1 diabetes: moving forward. Lancet Diabetes Endocrinol 6(7):516\u2013517. https:\/\/doi.org\/10.1016\/s2213-8587(18)30107-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"5456_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/dme.12792","volume":"32","author":"S Roze","year":"2015","unstructured":"Roze S, Smith-Palmer J, Valentine W, de Portu S, Norgaard K, Pickup JC (2015) Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Diabet Med 32(11):1415\u20131424. https:\/\/doi.org\/10.1111\/dme.12792","journal-title":"Diabet Med"},{"issue":"9","key":"5456_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1464-5491.2005.01576.x","volume":"22","author":"S Roze","year":"2005","unstructured":"Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ (2005) Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Diabet Med 22(9):1239\u20131245. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01576.x","journal-title":"Diabet Med"},{"issue":"10","key":"5456_CR28","doi-asserted-by":"publisher","first-page":"e1002945","DOI":"10.1371\/journal.pmed.1002945","volume":"16","author":"A Ochs","year":"2019","unstructured":"Ochs A, McGurnaghan S, Black MW et al (2019) Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study. PLoS Med 16(10):e1002945. https:\/\/doi.org\/10.1371\/journal.pmed.1002945","journal-title":"PLoS Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05456-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T13:04:03Z","timestamp":1625058243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05456-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5456"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05456-w","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}